Delta Hepatitis and Liver Disease in Hemophiliacs

NCT00005304 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2020-04-07

No results posted yet for this study

Summary

To determine the prevalence of hepatitis delta virus (HDV) in a large cohort of hemophiliacs and to elucidate the role of HDV in the development and progression of liver disease in this population.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • Baylor College of Medicine

    lead OTHER

Eligibility

Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1986-09-30
Completion
1991-09-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005304 on ClinicalTrials.gov